| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Cancer Medicine, The University of Sydney, New South Wales 2006, Australia [E. J. D., W. A. C., N. S.]; Central Sydney Area Health Service Electron Microscopy Unit, Concord Hospital, Concord, New South Wales 2139, Australia [S. B.]; and Darryl Rideout Structural Bioinformatics, Inc., San Diego, California [D. C. R.]
Proton nuclear magnetic resonance (NMR) spectroscopy, histological lipid staining, and electron microscopy were used to assess the biochemical and structural changes induced by treating the cultured human breast cell line HBL-100 with the cationic lipophilic phosphonium salts p-(triphenylphosphoniummethyl) benzaldehyde chloride (drug A) and [4-(hydrazinocarboxy)-1-butyl] tris-(4-dimethylaminophenyl) phosphonium chloride (drug B). The major biochemical change detected by 1H NMR in drug-treated cells was a significant time- and concentration-dependent increase in lipid acyl chain resonances arising from mobile lipids. The amount of NMR-visible lipid strongly correlated with morphometric measurements of oil red O-staining lipid detected in the cytoplasm by light microscopy. Ultrastructural investigations revealed substantial damage to mitochondria and the progressive development of lipid droplets accompanied by end-stage autophagic vacuoles, in the form of densely staining myelinoid bodies, after treatment of HBL-100 cells with drug B at the IC50. No apparent increase in acid phosphatase activity was observed using electron microscopy, indicating that the accumulation of phospholipids in myelinoid bodies may result from substrate inundation of the lysosome, rather than increased lysosomal activity. These results indicate a potential role for lysosomal lipid catabolism in the formation of NMR-visible lipids in models of cytotoxic insult.
This article has been cited by other articles:
![]() |
G. J. Arismendi-Morillo and A. V. Castellano-Ramirez Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies J. Electron Microsc. (Tokyo), January 1, 2008; 57(1): 33 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Glunde, V. Raman, N. Mori, and Z. M. Bhujwalla RNA Interference-Mediated Choline Kinase Suppression in Breast Cancer Cells Induces Differentiation and Reduces Proliferation Cancer Res., December 1, 2005; 65(23): 11034 - 11043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lindskog, C. Spenger, J. Jarvet, A. Graslund, and P. Kogner Predicting Resistance or Response to Chemotherapy by Proton Magnetic Resonance Spectroscopy in Neuroblastoma J Natl Cancer Inst, October 6, 2004; 96(19): 1457 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Griffin, K. K. Lehtimaki, P. K. Valonen, O. H. J. Grohn, M. I. Kettunen, S. Yla-Herttuala, A. Pitkanen, J. K. Nicholson, and R. A. Kauppinen Assignment of 1H Nuclear Magnetic Resonance Visible Polyunsaturated Fatty Acids in BT4C Gliomas Undergoing Ganciclovir-Thymidine Kinase Gene Therapy-induced Programmed Cell Death Cancer Res., June 15, 2003; 63(12): 3195 - 3201. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |